COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Sep. 30, 2021
Weighted Average Discount Rate Operating Lease	9.10%		9.10%
Additional Deposit Amount		$ 200,000		$ 200,000	$ 1,900,000
Increase In Right Of Use Asset And Liability			$ 1,100,000
Operating Lease Liabilities	$ 2,100,000		2,100,000
Research And Development Expenses			35,500,000
Net Of Discount			11,800,000
Operating Lease Right Of Use Assets	2,000,000.0		2,000,000.0		2,100,000
Current Balance	200,000		200,000		100,000
Operating Lease Expense	$ 90,000	66,000	181,000	132,000
Operating Lease Payment			$ 138,000	111,000
Weighted Average Time To Maturity			9 years 3 months 18 days
Landlord [Member]
Interest Rate	8.45%		8.45%
Lease Description			The repayment includes a base rent which escalates at 3% each year plus interest that accrues at 13.75% per year
Financing Arrangement			$ 11,100,000
Final Amount Received			800,000
Payments Made By Landlord			2,400,000
Ergomed [Member]
Research And Development Expenses	$ 200,000	$ 400,000	400,000	100,000.0
Net Of Discount			$ 11,800,000.0
Weighted Average Time To Maturity			6 years 7 months 6 days
Clinical Service Trial			$ 12,000,000
October 1, 2019 [Member] | Transaction One [Member]
Weighted Average Discount Rate	8.45%		8.45%
Net Book Value Of The Finance Lease Right Of Use Asset	$ 11,800,000		$ 11,800,000		12,700,000
Balance Of The Finance Lease Liability	$ 14,000,000.0		14,000,000.0		$ 13,800,000
Cash Paid Related To Finance Leases			1,300,000	1,000,000.0
Cash Paid Related To Finance Leases Interest			$ 600,000	$ 600,000.0